Drug Profile
Interleukin-2-dextran complex
Alternative Names: IL-2-dextran complex; IL-2-encapsulated dextran micropheres; OctoDEX™-IL-2; sustained release IL-2Latest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator OctoPlus
- Class Adjuvants; Antineoplastics; Immunotherapies; Interleukins; Lymphokines
- Mechanism of Action Immunostimulants; Interleukin 2 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 14 May 2008 Discontinued - Preclinical for Cancer in Netherlands (unspecified route)
- 18 Aug 2003 Preclinical trials in Cancer in Netherlands (unspecified route)